Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. (ATNM) — Form 8-K: Current report
About this filing
Actinium Pharmaceuticals, Inc. (ATNM) filed an 8-K on Oct 15, 2026 reporting an executive or director change or pay arrangement (Item 5.02) and a Regulation FD disclosure (Item 7.01), with exhibits (Item 9.01).
Key facts
- Item 5.02 · Executive or director change or pay arrangement
- Item 7.01 · Regulation FD disclosure
- Item 9.01 · Financial statements and exhibits
More ATNM filings
- 4
Filed Oct 16, 2026
- 3
Filed Oct 16, 2026
- ARS
Filed Oct 16, 2026
- DEF 14A
Filed Oct 16, 2026
- S-8
Filed Oct 9, 2026
- 3
Filed Sep 10, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.